Ryght and Lucem Health partner to advance disease detection and treatment with AI technology



LAGUNA BEACH, Calif., Feb. 27, 2024 /PRNewswire/ — Ryght, an innovator in generative AI (GenAI) technology for life science companies, today announced a partnership with Lucem Health to deploy applications that incorporate Ryght’s GenAI capabilities into the Lucem Health platform. The collaboration aims to enable Lucem Health to add GenAI to its AI SolutionOps platform and use it to enhance the company’s early disease detection and treatment acceleration solutions.

Lucem Health and Ryght will leverage specialized access to Ryght’s advanced GenAI technology, which utilizes various large language models (LLMs) fine-tuned for the sector. The technology will enable Lucem Health to develop new insights from longitudinal patient …

Full story available on Benzinga.com


Leave a Reply

Your email address will not be published. Required fields are marked *